Patents Assigned to EDGEMONT PHARMACEUTICALS
  • Sustained Release Formulations of Lorazepam
    Publication number: 20150174078
    Abstract: A pharmaceutical composition for delivering lorazepam in a prolonged fashion is achieved with prolonged release lorazepam pharmaceutical beads. The composition typically contains sustained release lorazepam beads and delayed sustained release lorazepam beads. The composition can provide once daily dosing that maintains 24 hour therapeutic effect under steady state conditions.
    Type: Application
    Filed: March 4, 2015
    Publication date: June 25, 2015
    Applicant: EDGEMONT PHARMACEUTICALS
    Inventors: Douglas A. Saltel, Michael Vachon